Cargando…

Liver-specific agents for contrast-enhanced MRI: role in oncological imaging

Liver-specific magnetic resonance (MR) contrast agents are increasingly used in evaluation of the liver. They are effective in detection and morphological characterization of lesions, and can be useful for evaluation of biliary tree anatomy and liver function. The typical appearances and imaging pit...

Descripción completa

Detalles Bibliográficos
Autores principales: Thian, Yee Liang, Riddell, Angela M., Koh, Dow-Mu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: e-Med 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893895/
https://www.ncbi.nlm.nih.gov/pubmed/24434892
http://dx.doi.org/10.1102/1470-7330.2013.0050
_version_ 1782299765216641024
author Thian, Yee Liang
Riddell, Angela M.
Koh, Dow-Mu
author_facet Thian, Yee Liang
Riddell, Angela M.
Koh, Dow-Mu
author_sort Thian, Yee Liang
collection PubMed
description Liver-specific magnetic resonance (MR) contrast agents are increasingly used in evaluation of the liver. They are effective in detection and morphological characterization of lesions, and can be useful for evaluation of biliary tree anatomy and liver function. The typical appearances and imaging pitfalls of various tumours at MR imaging performed with these agents can be understood by the interplay of pharmacokinetics of these contrast agents and transporter expression of the tumour. This review focuses on the applications of these agents in oncological imaging.
format Online
Article
Text
id pubmed-3893895
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher e-Med
record_format MEDLINE/PubMed
spelling pubmed-38938952014-06-13 Liver-specific agents for contrast-enhanced MRI: role in oncological imaging Thian, Yee Liang Riddell, Angela M. Koh, Dow-Mu Cancer Imaging Review Liver-specific magnetic resonance (MR) contrast agents are increasingly used in evaluation of the liver. They are effective in detection and morphological characterization of lesions, and can be useful for evaluation of biliary tree anatomy and liver function. The typical appearances and imaging pitfalls of various tumours at MR imaging performed with these agents can be understood by the interplay of pharmacokinetics of these contrast agents and transporter expression of the tumour. This review focuses on the applications of these agents in oncological imaging. e-Med 2013-12-30 /pmc/articles/PMC3893895/ /pubmed/24434892 http://dx.doi.org/10.1102/1470-7330.2013.0050 Text en © 2013 International Cancer Imaging Society
spellingShingle Review
Thian, Yee Liang
Riddell, Angela M.
Koh, Dow-Mu
Liver-specific agents for contrast-enhanced MRI: role in oncological imaging
title Liver-specific agents for contrast-enhanced MRI: role in oncological imaging
title_full Liver-specific agents for contrast-enhanced MRI: role in oncological imaging
title_fullStr Liver-specific agents for contrast-enhanced MRI: role in oncological imaging
title_full_unstemmed Liver-specific agents for contrast-enhanced MRI: role in oncological imaging
title_short Liver-specific agents for contrast-enhanced MRI: role in oncological imaging
title_sort liver-specific agents for contrast-enhanced mri: role in oncological imaging
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893895/
https://www.ncbi.nlm.nih.gov/pubmed/24434892
http://dx.doi.org/10.1102/1470-7330.2013.0050
work_keys_str_mv AT thianyeeliang liverspecificagentsforcontrastenhancedmriroleinoncologicalimaging
AT riddellangelam liverspecificagentsforcontrastenhancedmriroleinoncologicalimaging
AT kohdowmu liverspecificagentsforcontrastenhancedmriroleinoncologicalimaging